A group of researchers has developed a new formulation for the only drug available on the market to treat helminths, as worms such as schistosomes and tapeworms are known. According to the World ...

The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard ...

The U.S. Food and Drug Administration (FDA) has approved HemiClor, a 12.5 mg chlorthalidone tablet developed by PRM Pharma, ...

Sustained-release naltrexone may slightly increase illicit opioid use and serious adverse events compared to opioid agonists, with uncertain effects on retention and acceptability. It may reduce ...

Online companies marketing directly to consumers are selling naltrexone, Viagra, and Ozempic. Some studies show Ozempic ...

Background: Research on low-dose-rate (LDR) brachytherapy for gynecological cancer primarily examines treatment toxicity while overlooking aspects such as sexual desire, arousal, orgasm, satisfaction, ...

Results from the first patient cohort (N=5) of an open-label proof of concept academic study with low-dose IL-2 and CTLA4-Ig demonstrated a rapid and durable statistically significant increase in ...

When Jimmy Johnson coached the Dallas Cowboys, he had a famous line about how he treated players differently. He once cut a special teamer for falling asleep in a meeting. When he was asked if he ...

Microsoft is offering a new choice to employees who are deemed low performers: Accept a payout to quit or risk termination on a performance improvement plan. An internal email sent to Microsoft ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical data. The latest results show a high starting dose, fast titration model ...

The fertility rate last year – 54.6 births for every 1,000 women of reproductive age – increased less than 1% from the record low in 2023, hovering well below rates from years earlier.